| Phrase | Consultant | Town | Special Interests |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, cyberknife - stereotactic radiotherapy, lymphoma, skin cancer, lung cancer and other lung tumours |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology, bladder cancer, testicular cancer, germ cell tumours, prostate cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, gynaecological cancers, skin cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast radiotherapy, lung radiotherapy, skin radiotherapy |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric oncology, haematological malignancies, radiotherapy |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, bladder tumours, stereotactic ablative radiotherapy, image-guided adaptive radiotherapy |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, thyroid cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck cancer, lung cancer, skin cancer, thyroid cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, Prostate cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, breast cancer, upper and lower gastrointestinal cancer, systemic therapy Iodine 131 MIBG for neuroendocrine tumours, gastrointestinal chemoradiotherapy, colorectal cancer |
